Literature DB >> 25218511

The Impact of Mitochondrial Fusion and Fission Modulation in Sporadic Parkinson's Disease.

Daniel Santos1, A Raquel Esteves, Diana F Silva, Cristina Januário, Sandra M Cardoso.   

Abstract

Accumulating data suggests that mitochondrial deficits may underline both sporadic and familial Parkinson's disease (PD) neurodegenerative process. Impairment of mitochondrial dynamics results in reactive oxygen species (ROS) production, decreases mitochondrial membrane potential, and could potentiate the accumulation of dysfunctional mitochondria. Excessive mitochondrial fragmentation is associated with the pathology of sporadic PD. Therefore, we modulated mitochondria fusion and fission in different sporadic PD cellular models. We found alterations in two proteins known to regulate mitochondrial fusion and fission events (OPA1 and Drp1, respectively). OPA1 long isoform cleavage seems to be, at least in part, responsible for mitochondrial fragmented pattern observed in sporadic PD cellular models. Moreover, mitochondrial fragmentation can also occur due to an increase in Drp1 that is translocated into the mitochondria by phosphorylation. To disclose the relevance of these alterations to the fragmentation of the mitochondrial network, we overexpressed OPA1 and knock down Drp1. OPA1 overexpression did not rescue MPP(+)-induced increase in ROS. Nevertheless, Drp1 knockdown due to an increase in mitochondrial elongation and interconnectivity rescued mitochondrial membrane potential and decreased ROS production in sporadic PD cells. Overall, our findings suggest that Drp1-dependent mitochondrial fragmentation plays a crucial role in mediating mitochondrial DNA induced mitochondria abnormalities and cellular dysfunction in sporadic PD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25218511     DOI: 10.1007/s12035-014-8893-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  64 in total

1.  Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease.

Authors:  Chang-Lin Liang; Tom T Wang; Kate Luby-Phelps; Dwight C German
Journal:  Exp Neurol       Date:  2006-09-28       Impact factor: 5.330

2.  The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease.

Authors:  A R Esteves; I Gozes; S M Cardoso
Journal:  Biochim Biophys Acta       Date:  2013-10-11

3.  Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons.

Authors:  Mark J Barsoum; Hua Yuan; Akos A Gerencser; Géraldine Liot; Yulia Kushnareva; Simone Gräber; Imre Kovacs; Wilson D Lee; Jenna Waggoner; Jiankun Cui; Andrew D White; Blaise Bossy; Jean-Claude Martinou; Richard J Youle; Stuart A Lipton; Mark H Ellisman; Guy A Perkins; Ella Bossy-Wetzel
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

4.  A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity.

Authors:  Xin Qi; Nir Qvit; Yu-Chin Su; Daria Mochly-Rosen
Journal:  J Cell Sci       Date:  2012-12-13       Impact factor: 5.285

5.  Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis.

Authors:  K Meuer; I E Suppanz; P Lingor; V Planchamp; B Göricke; L Fichtner; G H Braus; G P H Dietz; S Jakobs; M Bähr; J H Weishaupt
Journal:  Cell Death Differ       Date:  2007-01-12       Impact factor: 15.828

6.  Regulation of mitochondrial morphology through proteolytic cleavage of OPA1.

Authors:  Naotada Ishihara; Yuu Fujita; Toshihiko Oka; Katsuyoshi Mihara
Journal:  EMBO J       Date:  2006-06-15       Impact factor: 11.598

7.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

8.  Creation and characterization of mitochondrial DNA-depleted cell lines with "neuronal-like" properties.

Authors:  S W Miller; P A Trimmer; W D Parker; R E Davis
Journal:  J Neurochem       Date:  1996-11       Impact factor: 5.372

9.  Influence of retinoic acid and lithium on proliferation and dopaminergic potential of human NT2 cells.

Authors:  I E Misiuta; S Saporta; P R Sanberg; T Zigova; A E Willing
Journal:  J Neurosci Res       Date:  2006-03       Impact factor: 4.164

10.  Ubiquitin proteasome system in Parkinson's disease: a keeper or a witness?

Authors:  Diogo Martins-Branco; Ana R Esteves; Daniel Santos; Daniela M Arduino; Russell H Swerdlow; Catarina R Oliveira; Cristina Januario; Sandra M Cardoso
Journal:  Exp Neurol       Date:  2012-08-19       Impact factor: 5.330

View more
  35 in total

1.  Water-Soluble Coenzyme Q10 Reduces Rotenone-Induced Mitochondrial Fission.

Authors:  Hai-Ning Li; Mary Zimmerman; Gaolin Z Milledge; Xiao-Lin Hou; Jiang Cheng; Zhen-Hai Wang; P Andy Li
Journal:  Neurochem Res       Date:  2017-02-11       Impact factor: 3.996

2.  Lactate Dehydrogenase Inhibition With Oxamate Exerts Bone Anabolic Effect.

Authors:  Alex M Hollenberg; Charles O Smith; Laura C Shum; Hani Awad; Roman A Eliseev
Journal:  J Bone Miner Res       Date:  2020-09-19       Impact factor: 6.741

Review 3.  Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis-A Review.

Authors:  Eun-Joo Shin; Hai-Quyen Tran; Phuong-Tram Nguyen; Ji Hoon Jeong; Seung-Yeol Nah; Choon-Gon Jang; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Res       Date:  2017-06-07       Impact factor: 3.996

4.  The Interaction of Mitochondrial Biogenesis and Fission/Fusion Mediated by PGC-1α Regulates Rotenone-Induced Dopaminergic Neurotoxicity.

Authors:  Kaige Peng; Likui Yang; Jian Wang; Feng Ye; Guorong Dan; Yuanpeng Zhao; Ying Cai; Zhihong Cui; Lin Ao; Jinyi Liu; Zhongmin Zou; Yan Sai; Jia Cao
Journal:  Mol Neurobiol       Date:  2016-06-07       Impact factor: 5.590

5.  Mitochondrial Metabolism Regulates Microtubule Acetylome and Autophagy Trough Sirtuin-2: Impact for Parkinson's Disease.

Authors:  Ana R Esteves; Daniela M Arduíno; Diana F Silva; Sofia D Viana; Frederico C Pereira; Sandra M Cardoso
Journal:  Mol Neurobiol       Date:  2017-02-06       Impact factor: 5.590

6.  Depletion of Mitofusin-2 Causes Mitochondrial Damage in Cisplatin-Induced Neuropathy.

Authors:  Ilja Bobylev; Abhijeet R Joshi; Mohammed Barham; Wolfram F Neiss; Helmar C Lehmann
Journal:  Mol Neurobiol       Date:  2017-01-21       Impact factor: 5.590

7.  Ultrastructural evidence for impaired mitochondrial fission in the aged rhesus monkey dorsolateral prefrontal cortex.

Authors:  Yury M Morozov; Dibyadeep Datta; Constantinos D Paspalas; Amy F T Arnsten
Journal:  Neurobiol Aging       Date:  2016-12-10       Impact factor: 4.673

Review 8.  Alterations in the E3 ligases Parkin and CHIP result in unique metabolic signaling defects and mitochondrial quality control issues.

Authors:  Britney N Lizama; Amy M Palubinsky; BethAnn McLaughlin
Journal:  Neurochem Int       Date:  2017-08-26       Impact factor: 3.921

9.  Perspective: Low Risk of Parkinson's Disease in Quasi-Vegan Cultures May Reflect GCN2-Mediated Upregulation of Parkin.

Authors:  Mark F McCarty; Aaron Lerner
Journal:  Adv Nutr       Date:  2021-03-31       Impact factor: 8.701

Review 10.  Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease.

Authors:  Eun-Joo Shin; Ji Hoon Jeong; Yeonggwang Hwang; Naveen Sharma; Duy-Khanh Dang; Bao-Trong Nguyen; Seung-Yeol Nah; Choon-Gon Jang; Guoying Bing; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Arch Pharm Res       Date:  2021-07-20       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.